Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Pediatr ; 24(1): 301, 2024 May 04.
Artigo em Inglês | MEDLINE | ID: mdl-38704544

RESUMO

BACKGROUND: We present a patient with retinopathy of prematurity (ROP) who developed worsening plus disease after complete regression of stage 3 ROP. The use of fundus fluorescein angiography (FFA) aided the visualization of occult neovascularization that caused the disease progression. CASE PRESENTATION: The patient was at high risk for ROP due to low birth weight of 690 g and gestational age of 25 weeks. After the diagnosis of stage 3 ROP in zone I without plus disease, she was treated initially with bilateral intravitreal bevacizumab (IVB) and followed by laser photocoagulation 5 weeks later. Despite the resolution of ROP stage, the plus disease worsened. Neither systemic risk factors nor skip laser areas were observed. Hence, FFA was performed and subsequently identified occult neovascularization with active leakage. Additional IVB and laser treatment in the capillary dropout area inside vascularized retina were added. The plus disease improved but mild arteriolar tortuosity persisted. CONCLUSIONS: Worsening of plus disease after completion of laser ablation and IVB with complete regression of stage 3 ROP is rare. Systemic risk factors such as continuous oxygen therapy and cardiovascular disease should be ruled out. FFA aided in identifying occult neovascularization and prompted further treatment.


Assuntos
Inibidores da Angiogênese , Bevacizumab , Angiofluoresceinografia , Injeções Intravítreas , Fotocoagulação a Laser , Neovascularização Retiniana , Retinopatia da Prematuridade , Humanos , Bevacizumab/uso terapêutico , Bevacizumab/administração & dosagem , Recém-Nascido , Inibidores da Angiogênese/uso terapêutico , Inibidores da Angiogênese/administração & dosagem , Feminino , Fotocoagulação a Laser/métodos , Neovascularização Retiniana/etiologia , Neovascularização Retiniana/tratamento farmacológico , Anticorpos Monoclonais Humanizados/uso terapêutico , Anticorpos Monoclonais Humanizados/administração & dosagem , Terapia Combinada
2.
Am J Case Rep ; 22: e928659, 2021 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-33712551

RESUMO

BACKGROUND Good syndrome (thymoma with immunodeficiency) is a frequently missed and forgotten entity. It is a rare cause of combined B and T cell immunodeficiency in adults. To date, fewer than 200 patients with Good syndrome have been reported in the literature. CASE REPORT We report a case of type AB Masaoka-Koga stage I thymoma which predated the evidence of immune dysregulation by 5 years, manifesting as bilateral cytomegalovirus retinitis, multiple bouts of pneumonia, and bronchiectasis in a HIV-seronegative 55-year-old man. Intravitreal ganciclovir was administered in addition to intravenous systemic ganciclovir, which resulted in severe neutropenic sepsis. A thorough immunodeficiency workup confirmed the presence of hypogammaglobulinemia with complete absence of B cells and reduced CD4/CD8 ratio. The patient responded well to monthly intravenous immunoglobulin replacement therapy, with no further episodes of infection since then. The immunoglobulin level doubled after 1 year of treatment. However, as the patient refused further intravitreal and CMV-targeted treatment, his vision did not recover. CONCLUSIONS Clinicians should be aware that thymoma can precede the onset of immunodeficiency. Clinical suspicion should be heightened in at-risk patients who present with multiple bouts of infection, particularly in thymoma cases with adult-onset immune dysfunction. It is of paramount importance to follow up those patients with annual clinical reviews and immunodeficiency screening.


Assuntos
Agamaglobulinemia , Timoma , Neoplasias do Timo , Adulto , Agamaglobulinemia/diagnóstico , Citomegalovirus , Humanos , Imunoglobulinas Intravenosas , Masculino , Pessoa de Meia-Idade , Timoma/diagnóstico , Neoplasias do Timo/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...